Bessemer Group Inc Taro Pharmaceutical Industries LTD Transaction History

Bessemer Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 07, 2019	SELL	$75.36 - $86.57 $204,602 - $235,037	-2,715 Closed	0 $0
Q2 2019 Jul 19, 2019	SELL	$83.92 - $108.88 $16,951 - $21,993	-202 Reduced 6.92%	2,715 $232,000
Q1 2019 May 13, 2019	BUY	$85.97 - $108.09 $171,424 - $215,531	1,994 Added 216.03%	2,917 $315,000
Q4 2018 Feb 12, 2019	BUY	$78.25 - $107.92 $1,173 - $1,618	15 Added 1.65%	923 $78,000
Q2 2018 Jul 25, 2018	SELL	$97.62 - $120.59 $122,025 - $150,737	-1,250 Reduced 57.92%	908 $105,000
Q4 2017 Jan 30, 2018	BUY	$104.5 - $126.38 $5,747 - $6,950	55 Added 2.62%	2,158 $226,000
Q3 2017 Nov 03, 2017	BUY	$97.26 - $116.2 $204,537 - $244,368	2,103	2,103 $237,000

17K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

Stay updated on Bessemer Group Inc with notifications on news.